Literature DB >> 20859711

Transient abnormal myelopoiesis in a cytogenetically normal neonate.

Kentaro Yanase1, Keisuke Kato, Nobuko Katayama, Yoko Mouri, Chie Kobayashi, Junko Shiono, Masakazu Abe, Ai Yoshimi, Kazutoshi Koike, Jun-Ichi Arai, Masahiro Tsuchida.   

Abstract

We present a cytogenetically normal neonate who developed transient abnormal myelopoiesis. The blasts showed trisomy 21. In contrast, fibroblasts, and PHA-stimulated peripheral blood demonstrated normal diploid line on extensive karyotyping. Direct sequencing of the DNA derived from the peripheral blood at overt disease revealed splice site mutation in the boundary of GATA1 exon 2. The patient received three courses of chemotherapy leading to complete remission. During the complete remission, there was neither mutation of GATA1 exon 2 nor trisomy 21, confirming somatic nature of both abnormalities. The patient is now free from the disease 12 months after remission. This case emphasizes the significance of trisomy 21 as the cause of transient abnormal myelopoiesis in Down syndrome.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20859711     DOI: 10.1007/s12185-010-0646-1

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  20 in total

1.  GATA1 mutation and trisomy 21 are required only in haematopoietic cells for development of transient myeloproliferative disorder.

Authors:  Emily Carpenter; Veronica Valverde-Garduno; Alex Sternberg; Chris Mitchell; Irene Roberts; Paresh Vyas; Ajay Vora
Journal:  Br J Haematol       Date:  2005-02       Impact factor: 6.998

2.  GATA1 mutation analysis demonstrates two distinct primary leukemias in a child with down syndrome; implications for leukemogenesis.

Authors:  Marit Hellebostad; Emily Carpenter; Henrik Hasle; Chris Mitchell; Paresh Vyas
Journal:  J Pediatr Hematol Oncol       Date:  2005-07       Impact factor: 1.289

Review 3.  Acute megakaryoblastic leukemia after transient myeloproliferative disorder with clonal karyotype evolution in a phenotypically normal neonate.

Authors:  Jacek M Polski; Csaba Galambos; Gordon B Gale; Cherie H Dunphy; H Lance Evans; Jacqueline R Batanian
Journal:  J Pediatr Hematol Oncol       Date:  2002-01       Impact factor: 1.289

4.  Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.

Authors:  Thomas Cushing; Carol L Clericuzio; Carla S Wilson; Jeffrey W Taub; Yubin Ge; Kaaren K Reichard; Stuart S Winter
Journal:  J Pediatr       Date:  2006-05       Impact factor: 4.406

5.  Transient neonatal myeloproliferative disorder without Down syndrome and detection of GATA1 mutation.

Authors:  Isis Quezado Magalhães; Alessandra Splendore; Mariana Emerenciano; Mara Santos Córdoba; Jose Carlos Córdoba; Paula Azevedo Allemand; Iris Ferrari; Maria S Pombo-de-Oliveira
Journal:  J Pediatr Hematol Oncol       Date:  2005-01       Impact factor: 1.289

6.  Involvement of a human gene related to the Drosophila spen gene in the recurrent t(1;22) translocation of acute megakaryocytic leukemia.

Authors:  T Mercher; M B Coniat; R Monni; M Mauchauffe; F Nguyen Khac; L Gressin; F Mugneret; T Leblanc; N Dastugue; R Berger; O A Bernard
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-08       Impact factor: 11.205

7.  Mutations in exon 2 of GATA1 are early events in megakaryocytic malignancies associated with trisomy 21.

Authors:  Liat Rainis; Dan Bercovich; Sabine Strehl; Andrea Teigler-Schlegel; Batia Stark; Jan Trka; Ninette Amariglio; Andrea Biondi; Inna Muler; Gideon Rechavi; Helena Kempski; Oskar A Haas; Shai Izraeli
Journal:  Blood       Date:  2003-03-20       Impact factor: 22.113

Review 8.  Down syndrome, transient myeloproliferative disorder, and infantile liver fibrosis.

Authors:  M Schwab; C Niemeyer; U Schwarzer
Journal:  Med Pediatr Oncol       Date:  1998-09

9.  Distinct clones are associated with the development of transient myeloproliferative disorder and acute megakaryocytic leukemia in a patient with Down syndrome.

Authors:  Hirokazu Kanegane; Sayaka Watanabe; Keiko Nomura; Gang Xu; Etsuro Ito; Toshio Miyawaki
Journal:  Int J Hematol       Date:  2007-10       Impact factor: 2.490

Review 10.  Tetrasomy 21 transient leukemia with a GATA1 mutation in a phenotypically normal trisomy 21 mosaic infant: case report and review of the literature.

Authors:  Claudio Sandoval; Sharon R Pine; Qianxu Guo; Sudha Sastry; Julian Stewart; David Kronn; Somasundaram Jayabose
Journal:  Pediatr Blood Cancer       Date:  2005-01       Impact factor: 3.167

View more
  3 in total

Review 1.  Acute megakaryoblastic leukemia with acquired trisomy 21 and GATA1 mutations in phenotypically normal children.

Authors:  Rintaro Ono; Daisuke Hasegawa; Shinsuke Hirabayashi; Takahiro Kamiya; Kenichi Yoshida; Satoko Yonekawa; Chitose Ogawa; Ryota Hosoya; Tsutomu Toki; Kiminori Terui; Etsuro Ito; Atsushi Manabe
Journal:  Eur J Pediatr       Date:  2014-09-30       Impact factor: 3.183

Review 2.  Transient leukemia in a newborn without Down syndrome: case report and review of the literature.

Authors:  Laurence Rozen; Sophie Huybrechts; Laurence Dedeken; Catherine Heijmans; Barbara Dessars; Pierre Heimann; Frédéric Lambert; Denis F Noubouossie; Alina Ferster; Anne Demulder
Journal:  Eur J Pediatr       Date:  2013-11-20       Impact factor: 3.183

3.  Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.

Authors:  Francesco Corazza; Annalisa Astolfi; Virginia Libri; Monica Franzoni; Salvatore Serravalle; Rosina Alessandroni; Fraia Melchionda; Andrea Pession
Journal:  Int J Hematol       Date:  2014-04-26       Impact factor: 2.319

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.